Abstract 3854: Inhibition of uracil DNA glycosylase (UDG) sensitizes cancer cells to thymidylate synthase inhibitors

Author(s):  
Yan Yan ◽  
Allison Condie ◽  
Stanton Gerson
2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Meredith S. Showler ◽  
Brian P. Weiser

Abstract It is well established that thymidylate synthase inhibitors can cause cellular toxicity through uracil DNA glycosylase (UNG2)-dependent pathways. Additionally, thymidylate synthase inhibitors and HDAC inhibitors are known to act synergistically in a variety of cancer types. A recent article from J. Transl. Med. links these together by demonstrating widespread depletion of UNG2 levels across a variety of cell lines treated with HDAC inhibitors. Recent findings suggest that UNG2 depletion by HDAC inhibitors would likely be an effective method to sensitize cells to thymidylate synthase inhibitors. This is particularly important for cancer types that are typically resistant to thymidylate synthase inhibitors, such as cells that are deficient in p53 activity.


Oncotarget ◽  
2016 ◽  
Vol 7 (37) ◽  
pp. 59299-59313 ◽  
Author(s):  
Yan Yan ◽  
Xiangzi Han ◽  
Yulan Qing ◽  
Allison G. Condie ◽  
Shashank Gorityala ◽  
...  

2018 ◽  
Vol 54 (51) ◽  
pp. 6991-6994 ◽  
Author(s):  
Yan Zhang ◽  
Qing-nan Li ◽  
Chen-chen Li ◽  
Chun-yang Zhang

We develop a label-free and high-throughput bioluminescence method for the sensitive detection of uracil DNA glycosylase through tricyclic cascade signal amplification.


Sign in / Sign up

Export Citation Format

Share Document